oxazoles has been researched along with Cancer of Skin in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (9.09) | 18.7374 |
| 1990's | 4 (36.36) | 18.2507 |
| 2000's | 1 (9.09) | 29.6817 |
| 2010's | 4 (36.36) | 24.3611 |
| 2020's | 1 (9.09) | 2.80 |
| Authors | Studies |
|---|---|
| Bazinet, A; Bhalla, K; Borthakur, G; Curry, JL; Daver, N; Heberton, M; Kadia, T; Khoury, JD; Kim, K; Konopleva, M; Loghavi, S; Miller, D; Pemmaraju, N; Pierce, S; Wilson, NR | 1 |
| Aplin, AE; Chervoneva, I; Erkes, DA; Nikbakht, N; Tiago, M | 1 |
| Afaq, F; Arumugam, A; Athar, M; Chaudhary, SC; Elmets, CA; Kopelovich, L; Singh, T; Srivastava, RK; Talwelkar, SS; Weng, Z | 1 |
| Gonzalez, FJ; Peters, JM; Yao, PL | 1 |
| Chen, YC; Wu, YH | 1 |
| Fujiki, H; Suganuma, M | 1 |
| Fujiki, H; Furuya, H; Matsunaga, S; Matsushima, R; Nishiwaki, S; Okabe, S; Suganuma, M; Sugimura, T; Yatsunami, J; Yoshizawa, S | 1 |
| Fujiki, H; Nishiwaki, S; Suganuma, M; Sugimura, T; Winyar, B; Yoshizawa, S | 1 |
| Fujiki, H; Furuya-Suguri, H; Fusetani, N; Kato, Y; Suganuma, M; Sugimura, T; Yasumoto, S; Yoshizawa, S | 1 |
| Fujiki, H; Nishiwaki, S; Schmitz, FJ; Suganuma, M; Sugimura, T; Winyar, B; Yoshizawa, S | 1 |
| Cortez, C; DiGiovanni, J; Harvey, RG; Sawyer, TW | 1 |
2 review(s) available for oxazoles and Cancer of Skin
| Article | Year |
|---|---|
Carcinogenic aspects of protein phosphatase 1 and 2A inhibitors.
Topics: Animals; Carcinogens; Disease Progression; Enzyme Inhibitors; Humans; Marine Toxins; Mice; Models, Molecular; Neoplasms; Neoplasms, Experimental; Okadaic Acid; Oxazoles; Protein Phosphatase 1; Protein Phosphatase 2; Rats; Skin Neoplasms; Stomach Neoplasms; Tetradecanoylphorbol Acetate; Tumor Necrosis Factor-alpha | 2009 |
Specific mechanistic aspects of animal tumor promoters: the okadaic acid pathway.
Topics: Animals; Antifungal Agents; Carcinogens; Ethers, Cyclic; Liver Neoplasms; Marine Toxins; Mice; Molecular Structure; Okadaic Acid; Oxazoles; Peptides, Cyclic; Pyrans; Rats; Skin Neoplasms; Spiro Compounds; Stomach Neoplasms; Structure-Activity Relationship | 1992 |
9 other study(ies) available for oxazoles and Cancer of Skin
| Article | Year |
|---|---|
Major clinical response in a patient with leukemia cutis treated with the bromodomain inhibitor PLX51107 and azacitidine.
Topics: Azacitidine; Humans; Leukemia; Leukemia, Myeloid, Acute; Oxazoles; Pyridines; Pyrroles; Skin Neoplasms | 2022 |
BET Inhibition Modifies Melanoma Infiltrating T Cells and Enhances Response to PD-L1 Blockade.
Topics: Animals; Antineoplastic Agents, Immunological; CD8-Positive T-Lymphocytes; Cell Growth Processes; Cell Line, Tumor; Disease Models, Animal; Drug Synergism; Forkhead Transcription Factors; Humans; Immunotherapy; Lymphocytes, Tumor-Infiltrating; Melanoma; Mice; Nerve Tissue Proteins; Oxazoles; Programmed Cell Death 1 Receptor; Pyridines; Pyrroles; Receptors, Cell Surface; Skin Neoplasms; T-Lymphocytes, Regulatory; Tumor Burden | 2019 |
Erb-041, an estrogen receptor-β agonist, inhibits skin photocarcinogenesis in SKH-1 hairless mice by downregulating the WNT signaling pathway.
Topics: Animals; Carcinogenesis; Cell Line, Tumor; Cell Proliferation; Down-Regulation; Estrogen Receptor beta; Female; Humans; Mice; Mice, Hairless; Oxazoles; Skin Neoplasms; Ultraviolet Rays; Wnt Signaling Pathway | 2014 |
Targeting estrogen receptor-β for the prevention of nonmelanoma skin cancer.
Topics: Animals; Carcinogenesis; Female; Humans; Oxazoles; Skin Neoplasms; Wnt Signaling Pathway | 2014 |
Linear Folliculotropic CD30-Positive Lymphomatoid Drug Reaction.
Topics: Biopsy, Needle; Diagnosis, Differential; Drug-Related Side Effects and Adverse Reactions; Facial Dermatoses; Female; Humans; Immunohistochemistry; Ki-1 Antigen; Lymphocytes; Lymphoma, T-Cell, Cutaneous; Middle Aged; Oxazoles; Risk Assessment; Skin Neoplasms; Withholding Treatment | 2017 |
Mechanisms of action of okadaic acid class tumor promoters on mouse skin.
Topics: Animals; Carcinogens; DNA; DNA Damage; DNA, Neoplasm; Enzyme Activation; Ethers, Cyclic; Genes, ras; Humans; Marine Toxins; Mice; Okadaic Acid; Oxazoles; Phosphoprotein Phosphatases; Phosphorylation; Protein Kinases; Protein Processing, Post-Translational; Proteins; Pyrans; Receptors, Drug; Skin; Skin Neoplasms; Structure-Activity Relationship | 1991 |
Calyculin A, an inhibitor of protein phosphatases, a potent tumor promoter on CD-1 mouse skin.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Binding Sites; Ethers, Cyclic; Female; Marine Toxins; Mice; Mice, Inbred Strains; Molecular Weight; Nuclear Proteins; Nucleolin; Okadaic Acid; Oxazoles; Phosphoprotein Phosphatases; Phosphoproteins; Phosphorylation; RNA-Binding Proteins; Skin; Skin Neoplasms | 1990 |
A new pathway of tumor promotion by the okadaic acid class compounds.
Topics: Animals; Binding, Competitive; Brain; Carcinogens; Cytosol; DNA, Neoplasm; Ethers, Cyclic; Humans; Marine Toxins; Mice; Molecular Structure; Mutation; Nuclear Proteins; Nucleolin; Okadaic Acid; Oxazoles; Phosphoprotein Phosphatases; Phosphoproteins; Protein Kinases; Proteins; Proto-Oncogene Proteins p21(ras); Pyrans; Receptors, Drug; RNA-Binding Proteins; Skin; Skin Neoplasms; Spiro Compounds; Structure-Activity Relationship | 1990 |
Synthesis of the tumorigenic 3,4-dihydrodiol metabolites of dibenz[a,j]anthracene and 7,14-dimethyldibenz[a,j]anthracene.
Topics: Animals; Benz(a)Anthracenes; Chemical Phenomena; Chemistry; Female; Isoxazoles; Mice; Oxazoles; Papilloma; Skin Neoplasms; Structure-Activity Relationship | 1988 |